» Articles » PMID: 15305412

Reevaluation of Prognostic Factors for Survival After Liver Resection in Patients with Hepatocellular Carcinoma in a Japanese Nationwide Survey

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2004 Aug 12
PMID 15305412
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Advances in the diagnosis and surgical treatment of hepatocellular carcinoma (HCC) have improved the prognosis for patients with HCC who undergo liver resection. The objective of this study was to evaluate prognostic predictors for patients with HCC who underwent liver resection in a Japanese nationwide data base.

Methods: In this study, the authors analyzed 12,118 patients with HCC in a Japanese nationwide data base who underwent liver resection between 1990 and 1999 and compared them with a previous analysis of patients between 1982 and 1989. All patients were evaluated for prognostic factors.

Results: During the last decade, the increases in patients who were without hepatitis B virus surface antigen, who had small tumors, and who had portal vein invasion were noted. The 5-year overall survival rates for patients with HCC improved to 50.5%, compared with < 40% in the previous analysis. A multivariate analysis using a stratified Cox proportional hazards model according to associated liver disease indicated that age, degree of liver damage, alpha-fetoprotein level, maximal tumor dimension, number of tumors, intrahepatic extent of tumor, extrahepatic metastasis, portal vein invasion, hepatic vein invasion, surgical curability, and free surgical margins were independent prognostic predictors for patients with HCC. Operative mortality decreased from 2.3% in 1990-1991 to 0.6% in 1998-1999.

Conclusions: Outcomes and operative mortality rates in patients with HCC improved during the last decade. Age, degree of liver damage, alpha-fetoprotein level, maximal tumor dimension, number of tumors, intrahepatic extent of tumor, extrahepatic metastasis, portal vein invasion, hepatic vein invasion, surgical curability, and free surgical margins were prognostic factors for patients with HCC who underwent liver resection.

Citing Articles

Surgical management for hepatocellular carcinoma with concurrent portal vein tumour thrombus and bile duct tumour thrombus: a case report.

Pham A, Duc Vu T, Nguyen T, Truong C, Pham A, Vu T Ann Med Surg (Lond). 2024; 86(6):3667-3673.

PMID: 38846841 PMC: 11152809. DOI: 10.1097/MS9.0000000000002035.


Surgical outcome and risk scoring to predict survival after hepatic resection for hepatocellular carcinoma with portal vein tumor thrombosis.

Kim T, Yang K, Choi G, Yang H, Kim D, Jo H Ann Hepatobiliary Pancreat Surg. 2024; 28(2):134-143.

PMID: 38720612 PMC: 11128794. DOI: 10.14701/ahbps.24-048.


Carbon-ion radiotherapy for hepatocellular carcinoma with major vascular invasion: a retrospective cohort study.

Kaneko T, Makishima H, Wakatsuki M, Hiroshima Y, Matsui T, Yasuda S BMC Cancer. 2024; 24(1):383.

PMID: 38532338 PMC: 10964684. DOI: 10.1186/s12885-024-12154-4.


Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study.

Bai T, Tang Z, Wang X, Chen J, Ye J, Lu S Langenbecks Arch Surg. 2024; 409(1):97.

PMID: 38488934 DOI: 10.1007/s00423-024-03249-4.


Surgical resection for hepatocellular carcinoma: a single-centre's one decade of experience.

Syaiful R, Mazni Y, Siagian N, Putranto A, Jeo W, Rahadiani N Ann Med Surg (Lond). 2024; 86(3):1289-1296.

PMID: 38463050 PMC: 10923277. DOI: 10.1097/MS9.0000000000001746.